Loading…
Takeda completed the sale of its TachoSil Fibrin Sealant Patch to Corza Health for €350 million ($422.4 million) in cash. The deal includes assets and licenses for development and commercialization, while Takeda retains the manufacturing facility in Linz, Austria.